ABBOTINDIA: Strong revenue and profit growth with robust margins and clean audit for the latest quarter

About this update from Abbott India Limited

Revenue and net profit grew year-over-year for the quarter and nine months ended December 31, 2024, with strong margins and higher EPS. Financials were reviewed and approved without modifications, and the company operates exclusively in the Pharmaceuticals segment.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Abbott India Limited